The report covers forecast and analysis for the point of care diagnostics market on a global and regional level. The study provides historic data of 2014 to 2016 along with a forecast for 2017 to 2022 based revenue (USD million). The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the point of care diagnostics market on a global level.
In order to give the users of this report a comprehensive view on the point of care diagnostics market, we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porters five forces model for the point of care diagnostics market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view on the point of care diagnostics market by segmenting the market based on product, prescription mode, end-user, and region. Based on products, the market can be segmented into glucose monitoring kits, cardio-metabolic monitoring kits, infectious diseases testing kits, coagulation monitoring kits, pregnancy and fertility testing kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits and others. Prescription mode includes prescription based test kits and over the counter tests. Different end users in this market are Hospitals, clinics, and ambulatory care settings. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India, and Brazil.
The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. The key players of the point of care diagnostics market include Roche Diagnostics, Alere Inc., Danaher Corporation, Abbott Laboratories, Johnson and Johnson, Instrumentation Laboratory, Trinity Biotech PLC, OraSure Technologies Inc, bioMerieux, Qiagen N.V. and Siemens Healthcare.
This report segments the global point of care diagnostics market as follows:
Point Of Care Diagnostics Market: Product Segment Analysis
Glucose Monitoring Kits
Cardiometabolic Monitoring Kits
HbA1c Testing Kits
Lipids Testing
Cardiac Markers
Blood Gas/Electrolytes Testing Kits
Infectious Diseases Testing Kits
Influenza Testing Kits
HIV Testing Kits
Hepatitis C Testing Kits
Sexually-transmitted Diseases (STDs) Testing Kits
Tropical Diseases Testing Kits
Healthcare-associated Infections (HAIs)
Respiratory Infections Testing Kits
Others
Coagulation Monitoring Kits
Prothrombin Time (PT/INR) Testing Kits
Activated Clotting Time (ACT/APTT) Testing Kits
Pregnancy and Fertility Testing Kits
Pregnancy Testing Kits
Fertility Testing Kits
Tumor/Cancer Markers
Urinalysis Testing Kits
Cholesterol Test Strips
Hematology Testing Kits
Drugs of Abuse Testing Kits
Fecal Occult Testing Kits
Others
Point Of Care Diagnostics Market: Prescription Mode Segment Analysis
Prescription-based Testing Kits
Over-the-counter (OTC) Testing Kits
Point Of Care Diagnostics Market: End User Segment Analysis
Hospitals
Clinics
Ambulatory Care Settings
Point Of Care Diagnostics Market: Regional Segment Analysis
North America
US
Europe
Germany
France
UK
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa